Author Archive for: aaronm23@mitash.com

The U.S. Food and Drug Administration has approved first Gene Therapy for rare genetic disease affecting brain and nervous system in kids. Lenmeldy (atidarsagene autotemcel) is the first FDA-approved gene therapy indicated for the treatment of children with pre-symptomatic late infantile, pre-symptomatic early juvenile or early symptomatic early juvenile metachromatic leukodystrophy (MLD). Metachromatic leukodystrophy is […]

A recent study published in the Influenza Other Respiratory Viruses journal examined the effectiveness of COVID-19 vaccines across various psychiatric disorders yielded promising outcomes. This study by Matthew Levy  and team from the VISION Network in four US determined if mental health conditions influence the efficacy of mRNA COVID-19 vaccines. The study encompassed data from a […]

In a recent study, the SavvyWire, a 0.035-inch pre-shaped guidewire with unique pacing properties and a distal pressure sensor, has demonstrated remarkable efficacy and safety during transcatheter aortic valve replacement (TAVR) procedures. The study, conducted across eight European centers, aimed to assess the device’s performance and safety in patients with severe aortic stenosis undergoing TAVR. […]

Rezafungin and caspofungin effective treatment options for invasive candidiasis suggest a new study published in the Lancet Infectious Diseases. Rezafungin, a new US Food and Drug Administration-approved, long-acting echinocandin to treat candidaemia and invasive candidiasis, was efficacious with a similar safety profile to caspofungin in clinical trials. We conducted pooled analyses of the phase 2 […]

Short-term very low calorie diets are safe for teenagers living with moderate to severe obesity when closely monitored by an experienced dietitian, new research to be presented at the European Congress on Obesity (ECO 2024), has found. In addition, many of the adolescents who took part in the Australian study found a very low calorie […]